Background illustration for clinical trials search

Paid Clinical Trials Edmonton

Discover 436 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

for
Low Back Pain
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06924671

Recruiting

Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

for
Preterm Birth, Premature Birth, Complication of Prematurity,
Location: Edmonton, Calgary, London, Hamilton, Toronto, Ottawa,
Sponsor: McMaster University

Sex: Female

Age: 18 - 55

Code: NCT05114096

Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

for
Latent Tuberculosis
Location: Edmonton, Calgary, Vancouver, Seattle WA, Denver CO,
Sponsor: Centers for Disease Control and Prevention

Sex: All

Age: 0+

Code: NCT03474029

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Edmonton, Markham, Toronto
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 4 - 18

Code: NCT04772079

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Edmonton, Mill Creek WA, Wheat Ridge CO,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 12 - 17

Code: NCT06979453

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for
Alopecia Areata
Location: Edmonton, Red Deer, Calgary, Kelowna, Missoula MT,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 12 - 17

Code: NCT07133308

Phase 3, Recruiting

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

for
Hidradenitis Suppurativa
Location: Edmonton, Omaha NE, Fremont CA, Sylmar CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07665437

Phase 3, Recruiting
New

This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer

for
Metastatic Non Small Cell Lung Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT06882174

Phase 2, Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Edmonton, Portland OR, Clovis CA, Iowa City IA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase 1, Phase 2, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Edmonton, Calgary, Reno NV, Aurora CO, Walnut Creek CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase 3, Recruiting

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

for
Anal Canal Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05040815

Phase 2, Recruiting

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

for
Carcinoma, Non-Small-Cell Lung
Location: Edmonton, Fargo ND, Sioux Falls SD, Columbus OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04165070

Phase 1, Phase 2, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: Edmonton, Vancouver, Albuquerque NM, Beverly Hills CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase 2, Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Edmonton, Seattle WA, Portland OR, Irving TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase 1, Phase 2, Recruiting

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

for
Neuroendocrine Tumors
Location: Edmonton, Saskatoon, Regina, Vancouver, London, Toronto,
Sponsor: Australasian Gastro-Intestinal Trials Group

Sex: All

Age: 18+

Code: NCT06345079

Phase 2, Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Edmonton, Calgary, Kelowna, Salt Lake City UT,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase 3, Recruiting

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Edmonton, Calgary, Fort Collins CO, Loveland CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06057402

Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Edmonton, Seattle WA, Tacoma WA, Eugene OR,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

for
Hematologic Neoplasms
Location: Edmonton, Calgary, Saskatoon, London, Hamilton,
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT04448184

Phase 3, Recruiting

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

for
Breast Cancer, Adverse Effect of Radiation Therapy
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: Female

Age: 18 - 70

Code: NCT02052102

Phase 2, Recruiting